Klotho Neurosciences Inc (KLTO) Stock Price, Quote & News

Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha,...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 931 6330

Website: klothoneuro.com

Address:

13576 Walnut Street, Suite A, Omaha, United States

Tycoon_Trader Nov. 14 at 2:47 PM

$KLTO The CEO has tremendous scientific knowledge, skills, and abilities, but lacks executive business abilities! He is heading towards a RS. This is why his COO left IMO.

0 · Reply

Beanie_Mojo Nov. 14 at 2:15 PM

$GOVX $HOLO $KLTO all stocks are falling apart - down under 😐

0 · Reply

Beanie_Mojo Nov. 14 at 12:06 AM

$KLTO ↔️$SMX Eachtime you avg. down This junk eats away more. What a s*** show 📺☠️

0 · Reply

GI812 Nov. 13 at 10:41 PM

$KLTO

0 · Reply

Boogerfloop19 Nov. 13 at 6:20 PM

$KLTO this blows they need to get together before March 31 or there will be another r/s

0 · Reply

Tycoon_Trader Nov. 12 at 10:48 PM

$KLTO This company needs to start buying its stock back even though it has a low float already. But this price per share is ridiculous especially considering the proprietary science foundation is way better than ThermoFisher scientific. KLTO's patents are worth way more than this!

0 · Reply

Beanie_Mojo Nov. 11 at 3:05 PM

$KLTO needs volume,

0 · Reply

Rod75b15 Nov. 11 at 2:32 PM

$KLTO https://finance.yahoo.com/news/klotho-neurosciences-wins-2025-biotech-150300137.html?guccounter=1

0 · Reply

Beanie_Mojo Nov. 10 at 8:43 PM

$KLTO

0 · Reply

Beanie_Mojo Nov. 10 at 8:41 PM

$KLTO is somethings brewing? ♨️ not a normal days pattern 🤔

0 · Reply

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Oct 16, 2025, 8:00 AM EDT - 4 weeks ago

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Oct 7, 2025, 6:20 PM EDT - 5 weeks ago

Klotho Neurosciences Announces Expiration of Letter of Intent

Sep 30, 2025, 8:30 AM EDT - 6 weeks ago

Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

Sep 8, 2025, 8:00 AM EDT - 2 months ago

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Aug 18, 2025, 8:30 AM EDT - 3 months ago

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Aug 12, 2025, 6:00 AM EDT - 3 months ago

Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology

Jul 25, 2025, 9:05 PM EDT - 3 months ago

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 24, 2025, 1:30 PM EDT - 4 months ago

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 22, 2025, 10:21 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets

Jul 16, 2025, 6:00 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules

Jul 10, 2025, 5:00 AM EDT - 4 months ago

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

Jun 30, 2025, 11:07 AM EDT - 4 months ago

This Penny Stock Exploded 500% In June: What You Need To Know

Jun 30, 2025, 2:00 AM EDT - 4 months ago

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

Jun 24, 2025, 5:00 AM EDT - 5 months ago

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

Jun 18, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS

Jun 16, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT

Jun 10, 2025, 11:00 AM EDT - 5 months ago

Klotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?

Jun 9, 2025, 7:00 AM EDT - 5 months ago

KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")

Jan 8, 2025, 11:00 AM EST - 11 months ago

Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Jun 26, 2024, 5:00 AM EDT - 1 year ago

ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein

Tycoon_Trader Nov. 14 at 2:47 PM

$KLTO The CEO has tremendous scientific knowledge, skills, and abilities, but lacks executive business abilities! He is heading towards a RS. This is why his COO left IMO.

0 · Reply

Beanie_Mojo Nov. 14 at 2:15 PM

$GOVX $HOLO $KLTO all stocks are falling apart - down under 😐

0 · Reply

Beanie_Mojo Nov. 14 at 12:06 AM

$KLTO ↔️$SMX Eachtime you avg. down This junk eats away more. What a s*** show 📺☠️

0 · Reply

GI812 Nov. 13 at 10:41 PM

$KLTO

0 · Reply

Boogerfloop19 Nov. 13 at 6:20 PM

$KLTO this blows they need to get together before March 31 or there will be another r/s

0 · Reply

Tycoon_Trader Nov. 12 at 10:48 PM

0 · Reply

Beanie_Mojo Nov. 11 at 3:05 PM

$KLTO needs volume,

0 · Reply

Rod75b15 Nov. 11 at 2:32 PM

$KLTO https://finance.yahoo.com/news/klotho-neurosciences-wins-2025-biotech-150300137.html?guccounter=1

0 · Reply

Beanie_Mojo Nov. 10 at 8:43 PM

$KLTO

0 · Reply

Beanie_Mojo Nov. 10 at 8:41 PM

$KLTO is somethings brewing? ♨️ not a normal days pattern 🤔

0 · Reply

SPYmyQQQ Nov. 10 at 4:24 PM

🎯 Target Hit 🏁 📨 From Nov 6, 2025 🪙 $KLTO 💵 Entry: $0.4620 ✅ Exit: $0.5320 💰 P/L: +15.15% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

Beanie_Mojo Nov. 10 at 1:36 PM

$KLTO up 5% down 10% up 3% down 8% up 7% down 12% ... ravage continues.....

0 · Reply

Joao78 Nov. 10 at 9:59 AM

$KLTO Nice. Shorts are out so we willl probably fly!

0 · Reply

LuckKev Nov. 10 at 12:41 AM

$KLTO 10cts soon after dillution , then R/S , repeat the process

0 · Reply

LuckKev Nov. 10 at 12:40 AM

$KLTO Scam marketing

0 · Reply

LuckKev Nov. 10 at 12:40 AM

$KLTO Longevity.🤣🤣🤣😂😂

0 · Reply

LuckKev Nov. 10 at 12:39 AM

$KLTO They will have to raise cash soon.... They have burnt 12 million last year , i guess they will burn 25 this year at least... They will have to raise cash...

0 · Reply

LuckKev Nov. 9 at 9:28 AM

$KLTO This will crash and finish badly!!!

0 · Reply

LuckKev Nov. 9 at 9:27 AM

$KLTO massively overpriced

0 · Reply

LuckKev Nov. 9 at 9:26 AM

$KLTO Dirty stock , you will puke

0 · Reply

LuckKev Nov. 9 at 9:25 AM

$KLTO I am shorting it , money printing scam...

0 · Reply

Market Cap	36.26M
Revenue (ttm)	0.00
Net Income (ttm)	-6.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	309,600
Avg Vol	2,038,190
Day's Range	N/A - N/A
Shares Out	70.34M
Stochastic %K	27%
Beta	10.03
Analysts	Strong Buy
Price Target	N/A